MackinST, NelsonSM, KerssensJJ, et al.Diabetes and pregnancy: national trends over a 15 year period. Diabetologia, 2018; 61: 1081–1088.
2.
FeigDS, DonovanLE, CorcoyR, et al.Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet, 2017; 390: 2347–2359.
3.
VoormolenDN, DeVriesJH, SansonRME, et al.Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes Obes Metab, 2018; 20: 1894–1902.
4.
StewartZA, WilinskaME, HartnellS, et al.Day-and-night closed-loop insulin delivery in a broad population of pregnant women with type 1 diabetes: a randomized controlled crossover trial. Diabetes Care, 2018; 41: 1391–1399.
5.
ScottEM, BilousRW, Kautzky-WillerA. Accuracy, user acceptability, and safety evaluation for the FreeStyle Libre Flash glucose monitoring system when used by pregnant women with diabetes. Diabetes Technol Ther, 2018; 20: 180–188.
6.
CharleerS, MathieuC, NobelsF, et al.Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: a real-world study. J Clin Endocrinol Metab, 2018; 103: 1224–1232.
7.
SenatMV, AffresH, LetourneauA, et al.Effect of glyburide vs subcutaneous insulin on perinatal complications among women with gestational diabetes: a randomized clinical trial. JAMA, 2018; 319: 1773–1780.
8.
WhiteSL, PasupathyD, SattarN, et al.Metabolic profiling of gestational diabetes in obese women during pregnancy. Diabetologia, 2017; 60: 1903–1912.
9.
HughesAE, NodzenskiM, BeaumontRN, et al.Fetal genotype and maternal glucose have independent and additive effects on birth weight. Diabetes, 2018; 67: 1024–1029.
10.
StewartZA, YamamotoJM, WilinskaME, et al.Adaptability of closed loop during labor, delivery, and postpartum: a secondary analysis of data from two randomized crossover trials in type 1 diabetes pregnancy. Diabetes Technol Ther, 2018; 20: 501–505.
11.
MurphyHR, BellR, CartwrightC, et al.Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study. Diabetologia, 2017; 60: 1668–1677.
12.
CrowtherCA, HillerJE, MossJR, et al.Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med, 2005; 352: 2477–2486.
13.
StewartZA, WilinskaME, HartnellS, et al.Closed-loop insulin delivery during pregnancy in women with type 1 diabetes. N Engl J Med, 2016; 375: 644–654.
14.
StewartZA, WilinskaME, HartnellS, et al.Day-and-night closed-loop insulin delivery in a broad population of pregnant women with type 1 diabetes: a randomized controlled crossover trial. Diabetes Care, 2018; 41: 1391–1399
15.
MurphyHR, KumareswaranK, ElleriD, et al.Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series. Diabetes Car. 2011; 34: 2527–2529.
16.
RowanJA, HagueWM, GaoW, BattinMR, MooreMP, MiGTI. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med, 2008; 358: 2003–2015.
17.
BalsellsM, Garcia-PattersonA, SolaI, RoqueM, GichI, CorcoyR. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ, 2015; 350: h102.
18.
MetzgerBE, ContrerasM, SacksDA, et al.The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Int J Gynecol Obstet, 2002; 78: 69–77.
